ESMO 2012 Press Release: Many cancer patients unaware of the personalised medicine revolution in oncology, survey shows
811 people surveyed by Prof Tejpar and colleagues
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
811 people surveyed by Prof Tejpar and colleagues
New trial results on pazopanib and temsirolimus have important implications for patients
Study opens a new door to more personalised treatment of advanced breast cancer
Studies presented at ESMO 2012 highlight challenges of cancer prevention
Take a stroll down memory lane and check out the `hot´ topics from past ESMO congresses in Vienna
New findings highlight the challenges of managing blood clotting in cancer patients
Head-to-head study compares of crizotinib with standard chemotherapy in this patient group
Promising new data from trials aimed at delaying resistance to BRAF inhibitors
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.